Amy C. Peterson Exelixis, Inc. (EXEL) insider trading activity

EXEL Quotes by TradingView

Amy C. Peterson is EVP Prod Dev & Med Aff & CMO of EXELIXIS, INC.. Currently has a direct ownership of 347,089 shares of EXEL, which is worth approximately $12.9 Million. The most recent transaction as insider was on Feb 26, 2025, when has been sold 52,192 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 347K
17.7% 3M change
7.75% 12M change
Total Value Held $12.9 Million

Amy C. Peterson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2025
BUY
Grant, award, or other acquisition
-
52,192 Added 13.07%
347,089 Common Stock
Nov 15 2024
SELL
Payment of exercise price or tax liability
$954,201 $35.05 p/Share
27,224 Reduced 8.45%
294,897 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
82,121 Added 20.31%
322,121 Common Stock
Aug 24 2023
BUY
Grant, award, or other acquisition
-
240,000 Added 50.0%
240,000 Common Stock

Also insider at

CTMX
CytomX Therapeutics, Inc. Healthcare
EVP, Chief Development Officer
ACP

Amy C. Peterson

EVP Prod Dev & Med Aff & CMO
South San Francisco, CA

Track Institutional and Insider Activities on EXEL

Follow EXELIXIS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

News

Receive news related to EXELIXIS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EXEL